Retrospective Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 706-715
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.706
Robotic resection of duodenal gastrointestinal stromal tumour: Preliminary experience from a single centre
Zhi-Peng Zhou, Xiang-Long Tan, Zhi-Ming Zhao, Yuan-Xing Gao, Yu-Yao Song, Yu-Ze Jia, Cheng-Gang Li
Zhi-Peng Zhou, Xiang-Long Tan, Zhi-Ming Zhao, Yuan-Xing Gao, Yu-Yao Song, Yu-Ze Jia, Cheng-Gang Li, Department of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing 100853, China
Author contributions: Zhou ZP and Tan XL contributed equally to this work, and are considered co-first authors; Zhou ZP and Tan XL analyzed and interpreted the data and wrote the article; Zhao ZM, Gao YX, Song YY and Jia YZ drafted the work and collected the data; Li CG designed the study and revised the article for important intellectual content.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Chinese PLA General Hospital (approval No. S2016-098-02).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors declare no conflicts of interest related to this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Cheng-Gang Li, MD, PhD, Associate Professor, Department of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China.
Received: March 11, 2021
Peer-review started: March 11, 2021
First decision: April 19, 2021
Revised: April 19, 2021
Accepted: June 4, 2021
Article in press: June 4, 2021
Published online: July 15, 2021
Research background

Surgical resection can achieve radical cure of duodenal gastrointestinal stromal tumors (DGISTs); however, there is no consensus on the choice of surgical technique.

Research motivation

The application of robotic surgery in the treatment of DGISTs.

Research objectives

Summarize the experience of a single center treating DGISTs by robotic resection.

Research methods

The perioperative and demographic outcomes of a consecutive series of patients who underwent robotic surgery to treat DGISTs were retrospectively analyzed.

Research results

Of the 28 patients enrolled, 11 patients underwent open surgery, and 17 patients underwent robotic surgery. All the tumours were R0 resected, and there were no significant differences in age, sex, tumour size, operation mode, postoperative hospital stay, tumour mitosis, incidence of postoperative complications, risk classification, postoperative targeted drug therapy or postoperative recurrence between the two groups (P > 0.05). Operation time and estimated blood loss in the robotic group were significantly different to those in the open surgery group (P < 0.05). No significant difference in recurrence-free survival was noted between the open surgery group and the robotic surgery group (P > 0.05).

Research conclusions

Robotic resection is safe and feasible for patients with DGISTs, and its therapeutic effect is equivalent to open surgery.

Research perspectives

Accumulation of experience in the treatment of DGISTs using robotic resection is required.